Actively Recruiting
The Influence of the Vaginal Microbiome on Clinical Pregnancy in Patients Undergoing a Euploid Embryo Transfer: a Prospective Blinded Multicentre Cohort Study
Led by Fundación IVI · Updated on 2024-10-15
1573
Participants Needed
10
Research Sites
76 weeks
Total Duration
On this page
Sponsors
F
Fundación IVI
Lead Sponsor
J
Juno
Collaborating Sponsor
AI-Summary
What this Trial Is About
Microorganisms such as bacteria live naturally on and in the bodies and are of great importance for our health. In the female body, almost 10% of all microorganisms live in the reproductive organs and especially in the vagina. Healthy bacteria in the vagina can defend against harmful bacteria and infections. However, it occasionally happens that the balance between healthy and harmful bacteria is disturbed, and it is believed that this could potentially harm pregnancy. However, there is not much evidence to prove a connection between an imbalance in bacteria and having an unsuccessful pregnancy. For this reason, the goal of our study is to determine if women with certain vaginal bacteria are more likely to experience pregnancy failures. If the investigators find this to be true, patients undergoing fertility treatment might be recommended regular tests in the future. If an imbalance in bacteria is found, doctors could provide treatment to restore a healthy vaginal environment, potentially improving the chances of a successful pregnancy.
CONDITIONS
Official Title
The Influence of the Vaginal Microbiome on Clinical Pregnancy in Patients Undergoing a Euploid Embryo Transfer: a Prospective Blinded Multicentre Cohort Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- ART patients undergoing the transfer of a euploid embryo
You will not qualify if you...
-
Patients with a body mass index (BMI) ≥35
- Patients with uncorrected uterine malformations
- Patients with a unicornuate uterus
- Patients with a bicornuate uterus
- Patients with any type of submucosal myoma
- Patients with an intramural myoma if ≥4 cm
- Patients with severe adenomyosis (>50% of the uterine corpus affected as defined by the MUSA criteria [19])
- Patients undergoing transfer of an embryo with a morphology score <4BC (according to the Gardner & Schoolcraft scoring system [18])
- Patients undergoing transfer of a day-7 embryo
- Patients who took antibiotics in the month prior to the embryo transfer (excluding antibiotics given following oocyte retrieval)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 10 locations
1
Ginefiv Barcelona
Barcelona, Barcelona, Spain, 08015
Actively Recruiting
2
IVI Barcelona
Barcelona, Barcelona, Spain, 08029
Actively Recruiting
3
IVI Bilbao
Bilbao, Bilbao, Spain, 48940
Actively Recruiting
4
IVI Madrid
Madrid, Madrid, Spain, 28023
Actively Recruiting
5
Ginefiv Madrid
Madrid, Madrid, Spain, 28043
Actively Recruiting
6
IVI Málaga
Málaga, Málaga, Spain, 29006
Actively Recruiting
7
Ginemed Sevilla
Seville, Sevilla, Spain, 41010
Actively Recruiting
8
IVI Valencia
Valencia, Valencia, Spain, 46015
Actively Recruiting
9
IVI Vigo
Vigo, Vigo, Spain, 36203
Actively Recruiting
10
IVI Zaragoza
Zaragoza, Zaragoza, Spain, 50018
Actively Recruiting
Research Team
K
Katharina Spath
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here